PEX28 Antibody

What is PEX28 and why is it important in peroxisome research?

PEX28 (Peroxin-28) is a multi-pass transmembrane protein localized to the peroxisome membrane in Saccharomyces cerevisiae. It plays a crucial role in regulating peroxisome number, size, and distribution by forming dynamic complexes at endoplasmic reticulum (ER)-peroxisome contact sites.

PEX28 is important in peroxisome research because:

• It regulates peroxisome proliferation through interactions with other peroxins

• It functions within a regulatory hierarchy upstream of Pex30, Pex31, and Pex32

• Deletion of PEX28 (pex28Δ) results in disrupted organelle distribution and peroxisome clustering

• It forms specific protein complexes that are essential for maintaining ER-peroxisome contact sites

The study of PEX28 contributes significantly to our understanding of peroxisome biogenesis, membrane contact site formation, and organelle communication in eukaryotic cells.

What applications is the PEX28 antibody most commonly used for?

The PEX28 antibody is commonly employed in several key experimental applications:

• Western Blotting (WB): For detecting PEX28 expression levels, particularly in genetic mutants (e.g., pex30Δ). This application allows researchers to quantify protein levels and assess changes under different conditions or in various mutant strains .

• Immunofluorescence (IF): For localizing PEX28 to discrete ER domains adjacent to peroxisomes. This technique enables visualization of PEX28's subcellular distribution and co-localization with other organelle markers.

• Immunoprecipitation (IP): For isolating PEX28-containing complexes for proteomic studies. This method is crucial for investigating protein-protein interactions and complex formation .

The selection of application depends on the specific research question. For protein quantification and expression analysis, Western blotting is preferred. For spatial distribution studies, immunofluorescence is optimal. For protein interaction studies, immunoprecipitation is most suitable.

How do I prepare yeast samples for optimal PEX28 antibody detection?

For optimal PEX28 antibody detection in yeast samples, follow these methodological steps:

For Western Blotting:

• Harvest whole-cell extracts from 2 OD units of exponentially growing cells or cells grown to diauxic shift

• Resuspend pelleted cells in 300 μL of 0.15 M NaOH and incubate on ice for 10 minutes

• Centrifuge at maximum speed for 2 minutes at 4°C

• Resuspend the pellet in sample buffer and heat at 65°C for 10 minutes

• Separate proteins by SDS-PAGE using pre-cast gels

• Transfer to PVDF membrane and analyze with PEX28 antibody (typically used at 1:1000 dilution)

For Immunoprecipitation:

• Harvest approximately 100 OD600 units of yeast culture grown in YPD

• Resuspend in 700 μl of lysis buffer (50mM Tris/HCl [pH7.4], 200mM NaCl, 1mM EDTA, 1mM PMSF, and protease inhibitor)

• Lyse cells with glass beads and clear lysates by low-speed centrifugation

• Pellet membranes at 45,000g for 25 minutes at 4°C using an ultracentrifuge

• Resuspend the crude membrane fraction in 600 μl lysis buffer

• Solubilize membranes with 1% decyl maltose neopentyl glycol (DMNG) for 2 hours on a rotating wheel at 4°C

• Clear solubilized membranes by centrifugation

• Isolate tagged proteins using appropriate magnetic beads (anti-Myc for Pex28-13xMyc)

This protocol is specifically optimized for membrane protein extraction, crucial for transmembrane proteins like PEX28.

What controls should I include when using PEX28 antibody in my experiments?

When using PEX28 antibody in experiments, include the following controls to ensure reliable and interpretable results:

For Western Blotting:

• Positive Control: Wild-type yeast lysate expressing PEX28

• Negative Control: pex28Δ yeast strain lysate

• Loading Control: A housekeeping protein such as Dpm1 (use mouse monoclonal 5C5A7 antibody at 1:10000 dilution)

• Molecular Weight Marker: To confirm the correct size of PEX28 (P38848, UniProt ID)

For Immunoprecipitation:

• Input Sample: Include 10% of the total extract used for immunoprecipitation to verify protein presence before pulldown

• Non-specific Antibody Control: Use an isotype-matched irrelevant antibody for immunoprecipitation

• Non-tagged Strain Control: Perform parallel IP with a non-tagged strain to control for non-specific binding

• Reciprocal IP: If studying interactions (e.g., between PEX28 and PEX30), perform IP in both directions

For Immunofluorescence:

• Secondary Antibody Only: To evaluate background fluorescence

• pex28Δ Strain: To confirm antibody specificity

• Co-localization Markers: Include established organelle markers (e.g., peroxisome markers)

These controls help distinguish between specific and non-specific signals, validate antibody specificity, and provide reference points for data interpretation.

How can I optimize PEX28 antibody for detecting protein complexes at membrane contact sites?

Detecting PEX28-containing complexes at membrane contact sites requires specialized approaches optimized for preserving membrane integrity and spatial relationships:

Optimized Immunoprecipitation Protocol:

• Use gentler membrane solubilization with 1% DMNG instead of stronger detergents like SDS, which may disrupt protein-protein interactions

• Maintain cold temperatures (4°C) throughout the procedure to preserve complex stability

• Include phosphatase inhibitors in addition to protease inhibitors to maintain post-translational modifications

• Use cross-linking agents (e.g., DSP or formaldehyde) prior to lysis to stabilize transient interactions

• Employ sequential immunoprecipitation (first pull down with anti-PEX28 antibody, then with antibodies against suspected partner proteins)

Advanced Imaging Approaches:

• Use super-resolution microscopy techniques (STORM, PALM, or STED) to visualize PEX28 at contact sites

• Employ proximity ligation assays (PLA) to detect PEX28 interactions with other proteins in situ

• Consider FRET-based approaches with fluorescently-tagged proteins to measure distances between PEX28 and interaction partners

Complex Detection Strategy:
When investigating the PEX28-PEX30-PEX32 trimeric complex, consider the following approach based on research findings:

This approach has been validated for detecting the mutual exclusivity of PEX28-PEX30-PEX32 vs. PEX30-PEX29 complexes .

What are the key considerations when interpreting PEX28 antibody results in mutant yeast strains?

When interpreting PEX28 antibody results in mutant yeast strains, consider these critical factors:

Protein Expression Levels:

• In pex28Δ mutants, expect complete absence of PEX28 signal (essential negative control)

• In pex30Δ or pex32Δ mutants, PEX28 expression may be altered due to regulatory feedback loops

• PEX28 deletion affects other peroxins - expect 60-80% drop in PEX30/PEX32 protein levels in pex28Δ mutants

Localization Changes:

• In wild-type cells, PEX28 localizes to discrete ER domains adjacent to peroxisomes

• In pex30Δ mutants, PEX28 localization may be compromised or diffuse

• Consider that changes in localization may not necessarily reflect changes in expression level

Functional Implications:
The table below summarizes key observations in PEX28 mutant studies:

Technical Considerations:

• Membrane protein extraction efficiency may vary between wild-type and mutant strains

• Secondary effects of mutations may complicate direct interpretation

• Growth conditions significantly affect peroxisome biogenesis - standardize culture conditions across experiments

• Consider genetic background effects when comparing different strain collections

To establish causal relationships, complement mutant phenotypes with wild-type PEX28 expression and observe rescue effects.

How can I use PEX28 antibody in combination with flow cytometry for advanced analyses?

While traditional applications of PEX28 antibody don't typically involve flow cytometry, adapting flow cytometric techniques for PEX28 analysis can provide quantitative insights into peroxisome biology:

Modified Protocol for Spheroplast Preparation:

• Digest yeast cell walls using zymolyase in isotonic buffer to create spheroplasts

• Fix spheroplasts with 4% paraformaldehyde (10 minutes at room temperature)

• Permeabilize with 0.1% Triton X-100 or 0.1% saponin

• Block with 5% BSA for 30 minutes

• Incubate with PEX28 antibody (1:100 dilution) for 1 hour

• Wash and incubate with fluorophore-conjugated secondary antibody

• Analyze using standard flow cytometry instrumentation

Applications of Flow Cytometry for PEX28 Research:

• Quantitative Expression Analysis: Measure PEX28 expression levels across populations of cells under different growth conditions

• Correlation with Peroxisome Abundance: Co-stain with peroxisomal matrix markers (e.g., GFP-SKL) to correlate PEX28 levels with peroxisome abundance

• Cell Cycle Analysis: Combine with DNA staining to analyze PEX28 expression through cell cycle phases

Advanced Sorting Applications:
Fluorescence-activated cell sorting (FACS) can be used for advanced applications:

• Isolate cell populations with varying PEX28 expression levels for downstream analysis

• Sort cells based on peroxisome abundance (using matrix markers) and correlate with PEX28 expression

• Use sorted populations for transcriptomic or proteomic analysis to identify factors co-regulated with PEX28

While these applications represent adaptations of established flow cytometry methods , they must be carefully optimized for PEX28 specifically, considering its membrane localization and relatively low abundance.

What are the most effective strategies for validating PEX28 antibody specificity?

Validating PEX28 antibody specificity is critical for research reliability. Implement these comprehensive validation strategies:

Genetic Validation:

• Null Mutant Control: Test antibody on pex28Δ strains, which should show no signal in any application

• Overexpression System: Analyze signal intensity correlation with controlled overexpression levels

• Tagged Reference: Compare antibody detection with epitope tag detection (e.g., Pex28-13xMyc detected with both PEX28 antibody and Myc antibody)

Biochemical Validation:

• Peptide Competition: Pre-incubate antibody with the immunizing peptide (TEEKEQSNPTIGRDS for C-terminal raised antibodies) to block specific binding

• Western Blot Analysis: Confirm single band at expected molecular weight (P38848)

• Mass Spectrometry Validation: Perform immunoprecipitation followed by mass spectrometry identification of captured proteins

Cross-Reactivity Assessment:

• Related Proteins: Test against close homologs (PEX29, PEX30, PEX31, PEX32)

• Species Specificity: Validate across different yeast species if working with non-S. cerevisiae models

• Multiple Antibody Comparison: If available, compare results with antibodies targeting different epitopes of PEX28

Immunofluorescence Validation:

• Co-localization: Confirm PEX28 antibody signal co-localizes with known peroxisome membrane and ER-peroxisome contact site markers

• Tagged Protein Overlap: Compare localization pattern with fluorescently tagged PEX28 (e.g., Pex28-GFP)

Thorough validation using multiple approaches provides confidence in antibody specificity. Document all validation steps according to best practices in antibody reporting to enhance reproducibility.

How can PEX28 antibody be used to study dynamic changes in peroxisome-ER contact sites?

PEX28 antibody can be leveraged to investigate the dynamic nature of peroxisome-ER contact sites through several advanced approaches:

Time-Course Experiments:

• Synchronize cells and collect samples at defined intervals

• Perform immunoprecipitation with PEX28 antibody followed by western blotting for interaction partners

• Quantify changes in complex composition over time

• Correlate with peroxisome biogenesis stages or metabolic shifts

Live Cell Imaging Combinations:

• Use fixed-cell immunofluorescence with PEX28 antibody as validation for live-cell studies using fluorescently tagged proteins

• Establish correlation between antibody-detected endogenous PEX28 and tagged version behavior

• Apply super-resolution microscopy techniques for detailed contact site architecture analysis

Metabolic Shift Experiments:
PEX28-containing complexes respond to metabolic conditions. Design experiments to capture these dynamics:

Perturbation Approaches:

• Pharmacological Interventions: Apply drugs affecting ER structure or lipid composition and monitor PEX28 complex changes

• Genetic Perturbations: Create conditional mutants of PEX28 partners and analyze effects on complex stability

• Stress Conditions: Apply oxidative stress and monitor changes in PEX28-containing contact sites

Quantitative Contact Site Metrics:
Develop quantitative measures of contact site dynamics using PEX28 antibody:

• Contact site number per cell (by immunofluorescence)

• Contact site size/extent (by electron microscopy with immunogold labeling)

• Molecular composition (by quantitative immunoprecipitation)

• Functional capacity (by lipid transfer assays correlated with PEX28 complex integrity)

These approaches collectively enable comprehensive investigation of the dynamic nature of PEX28-dependent peroxisome-ER contact sites.

Why might I observe inconsistent PEX28 antibody signals in Western blotting?

Inconsistent PEX28 antibody signals in Western blotting can stem from several methodological challenges specific to this transmembrane protein:

Sample Preparation Issues:

• Incomplete Membrane Protein Extraction: PEX28 is a multi-pass transmembrane protein that requires thorough solubilization. Ensure complete membrane fraction preparation with appropriate detergents like DMNG (1% final concentration)

• Protein Degradation: Include fresh protease inhibitors in all buffers and maintain cold temperatures throughout processing

• Aggregation During Heating: Membrane proteins may aggregate when boiled; heat samples at 65°C for 10 minutes instead of boiling

Technical Variables:

• Transfer Efficiency: Hydrophobic membrane proteins like PEX28 require optimized transfer conditions. Use PVDF membranes (not nitrocellulose) and consider adding 0.1% SDS to transfer buffer

• Blocking Interference: Excessive blocking can mask epitopes; try 3% BSA instead of 5% milk for blocking

• Antibody Concentration: Titrate antibody concentration between 1:500 and 1:2000 to find optimal signal-to-noise ratio

Biological Variables:

• Expression Level Variations: PEX28 expression varies with growth conditions; standardize culture conditions precisely

• Yeast Strain Differences: Different genetic backgrounds may affect antibody accessibility to epitopes

• Post-translational Modifications: Consider that phosphorylation or other modifications may affect antibody recognition

Troubleshooting Approach:

• Include appropriate controls in every experiment (wild-type, pex28Δ)

• Perform a dot blot test to confirm antibody reactivity before full Western blot

• Try membrane stripping and reprobing if signals are weak

• Consider alternative membrane protein extraction methods if standard protocols fail

When troubleshooting, systematically vary one parameter at a time while keeping others constant to identify the source of inconsistency.

What is the best approach for optimizing PEX28 antibody concentration for different applications?

Optimizing PEX28 antibody concentration requires methodical titration for each application, with different considerations for various techniques:

Western Blotting Optimization:

• Initial Titration: Test a broad range (1:500, 1:1000, 1:2000, 1:5000) using the same positive control sample

• Signal Evaluation: Assess signal-to-noise ratio, not just signal strength

• Secondary Antibody Balance: Adjust secondary antibody concentration proportionally (typically 1:5000 to 1:10000)

• Exposure Optimization: For each antibody dilution, capture multiple exposure times to determine optimal signal development

• Quantitative Assessment: Plot signal intensity versus antibody concentration to identify the linear range

Immunofluorescence Optimization:

• Start Conservative: Begin with higher concentration (1:100) and titrate to higher dilutions

• Background Control: Include secondary-only controls for each dilution

• Competition Test: For each dilution, run a parallel sample with antibody pre-incubated with immunizing peptide

• Signal Specificity: Compare wild-type versus pex28Δ samples at each concentration

Immunoprecipitation Optimization:

• Antibody-to-Sample Ratio: Test different amounts of antibody (2μg, 5μg, 10μg) per 100 OD600 of culture

• Pre-clearing Step: Introduce a pre-clearing step with protein A/G beads to reduce non-specific binding

• Incubation Time: Optimize between 2-16 hours at 4°C

• Sequential IP: For complex studies, determine the optimal antibody amount for efficient first-round depletion

Optimization Matrix Example:

Document all optimization steps in a laboratory notebook and maintain consistent conditions for subsequent experiments once optimized parameters are established.

How can I distinguish between specific and non-specific signals when using PEX28 antibody?

Distinguishing specific from non-specific signals requires rigorous controls and analytical approaches:

Critical Controls:

• Genetic Knockout: The pex28Δ strain provides the gold standard negative control - any signal in this sample is non-specific

• Peptide Competition: Pre-incubate PEX28 antibody with excess immunizing peptide to block specific binding sites

• Isotype Control: Use matched concentration of irrelevant antibody from same species/isotype

• Secondary-Only Control: Omit primary antibody to assess secondary antibody background

Analytical Approaches:

• Signal Characteristics Assessment: Specific signals should:

  • Appear at the predicted molecular weight (for Western blots)

  • Localize to expected subcellular compartments (for immunofluorescence)

  • Show expected changes in response to experimental manipulations

  • Be absent in knockout controls

• Multiple Detection Methods: Validate findings using orthogonal approaches:

  • If observed by Western blot, confirm by immunofluorescence

  • If detected by immunoprecipitation, validate by proximity labeling

• Signal Quantification: Perform quantitative analysis comparing signal intensity between:

  • Specific antibody vs. isotype control

  • With vs. without peptide competition

  • Wild-type vs. knockout samples

Scientific Documentation Requirements:
When publishing results using PEX28 antibody, include:

• Antibody validation data

• All control experiments performed

• Quantification methods used to distinguish specific from non-specific signals

• Raw, unedited blot/image data in supplementary materials

How might PEX28 antibody be used in studying human peroxisomal disorders?

While PEX28 is a yeast peroxin, research using PEX28 antibody has implications for understanding human peroxisomal disorders through comparative studies and model systems:

Translational Research Approaches:

• Functional Conservation Analysis: Use PEX28 antibody in yeast to characterize interactions with homologs of human peroxins

• Disease Mutation Modeling: Introduce mutations corresponding to human peroxisomal disorder mutations into yeast PEX28 and analyze effects using the antibody

• Cross-Species Validation: Test whether PEX28 antibody recognizes structural homologs in human cells or other model organisms

Relevant Research Areas:

• Peroxisome Biogenesis Disorders (PBDs): Study how PEX28-dependent contact sites in yeast inform understanding of human peroxisome formation

• Metabolic Disorders: Investigate how disruption of PEX28-containing complexes affects metabolic functions conserved between yeast and human peroxisomes

• Zellweger Spectrum Disorders: Explore parallels between PEX28 contact site defects and human PEX gene mutations

Methodological Adaptations:

• Heterologous Expression Systems: Express human PEX proteins in yeast pex28Δ strains and use PEX28 antibody to study complex formation

• Chimeric Protein Analysis: Create chimeras between yeast PEX28 and human homologs, then use the antibody to track localization and function

• Structural Insights: Use PEX28 antibody to isolate protein complexes for structural studies that may inform human peroxin interactions

While direct application of yeast PEX28 antibody to human samples is limited by species specificity, the fundamental insights gained from yeast studies using this antibody continue to provide valuable conceptual frameworks for understanding human peroxisomal disorders.

What novel flow cytometry approaches can be combined with PEX28 antibody for single-cell analysis?

Integrating flow cytometry with PEX28 antibody analysis enables sophisticated single-cell approaches for peroxisome biology research:

Advanced Flow Cytometry Applications:

• Multiparameter Analysis: Combine PEX28 antibody with other peroxisomal markers to create multidimensional profiles of peroxisome status

• Cell Cycle Correlation: Integrate DNA content staining to analyze PEX28 expression throughout the cell cycle

• Metabolic State Assessment: Use metabolic dyes alongside PEX28 detection to correlate peroxisome contact sites with cellular metabolic status

Innovative Methodological Approaches:

• Intracellular Flow Cytometry Protocol:

  • Fix yeast cells with 4% paraformaldehyde (10 minutes)

  • Permeabilize cell wall with zymolyase and membrane with 0.1% Triton X-100

  • Block with 3% BSA (30 minutes)

  • Incubate with PEX28 antibody (1:100, 1 hour)

  • Wash and incubate with fluorophore-conjugated secondary antibody

  • Analyze using standard flow cytometry instrumentation

• Imaging Flow Cytometry Applications:

  • Combines flow cytometry throughput with microscopy resolution

  • Enables visualization of PEX28 localization while quantifying expression levels

  • Allows correlation of peroxisome morphology with PEX28 distribution

  • Provides statistical power through analysis of thousands of cells

• Fluorescence-Activated Cell Sorting (FACS) Integration:

  • Sort cells based on PEX28 antibody signal intensity

  • Isolate subpopulations with different PEX28 expression levels

  • Perform downstream transcriptomic or proteomic analysis on sorted populations

  • Cultivate sorted populations to assess hereditary versus transient expression patterns

These advanced flow cytometric approaches provide unprecedented insights into cell-to-cell variability in peroxisome biology and PEX28 function, moving beyond population averages to single-cell resolution.

What are the key considerations for selecting and validating a PEX28 antibody for peroxisome research?

When selecting and validating a PEX28 antibody for peroxisome research, consider these critical factors:

Selection Criteria:

• Target Specificity: Choose antibodies raised against specific PEX28 epitopes, preferably with known functional significance

• Host Species: Consider experimental compatibility - rabbit polyclonal antibodies are common for PEX28 detection

• Application Versatility: Select antibodies validated for multiple applications (WB, IF, IP) if diverse experiments are planned

• Epitope Location: For transmembrane proteins like PEX28, antibodies targeting accessible domains (e.g., C-terminal regions) often perform better

• Production Method: Evaluate whether monoclonal specificity or polyclonal epitope coverage better suits your research needs

Validation Requirements:

• Genetic Controls: Always validate against pex28Δ strains to confirm specificity

• Cross-Reactivity Testing: Assess potential cross-reactivity with related peroxins (PEX29, PEX30, PEX32)

• Multiple Technique Verification: Confirm specificity across different applications (WB, IF, IP)

• Quantitative Assessment: Determine detection limits and dynamic range

• Batch Consistency: For critical experiments, test multiple antibody lots for consistent performance

Documentation Standards:

• Record complete antibody information (source, catalog number, lot, dilution)

• Document all validation experiments performed

• Maintain images of control experiments

• Report validation details in publications according to antibody reporting guidelines

Long-term Considerations:

• Antibody stability and storage conditions (-20°C or -80°C, with or without glycerol)

• Potential for alternative detection strategies (e.g., epitope tagging) as complementary approaches

• Reproducibility across different experimental conditions and yeast strains

Thorough validation not only ensures experimental reliability but also contributes to broader scientific reproducibility in the peroxisome research field.

How is PEX28 antibody research contributing to our understanding of membrane contact sites?

PEX28 antibody research has made significant contributions to our understanding of membrane contact sites, particularly in the context of ER-peroxisome communications:

Fundamental Discoveries:

• Identification of PEX28 as a key component of ER-peroxisome contact sites, forming a complex with PEX30 and PEX32

• Demonstration that PEX28-containing complexes are distinct from PEX30/PEX29 complexes at nuclear-vacuolar junctions

• Establishment of a hierarchical relationship where PEX28 functions upstream of PEX30, PEX31, and PEX32 in peroxisome proliferation

• Discovery that loss of PEX28 leads to peroxisome clustering and disrupted organelle distribution

Methodological Advances:

• Development of optimized immunoprecipitation protocols for membrane contact site protein complexes

• Establishment of quantitative approaches to measure contact site abundance and composition

• Integration of functional assays with structural studies of contact site components

Broader Impact on Cell Biology:
PEX28 antibody research has contributed to several paradigm shifts in our understanding of organelle communication:

• From Isolated Organelles to Interactive Networks: Research using PEX28 antibody helped establish peroxisomes as integrated components of a cellular membrane network rather than isolated organelles

• Dynamic Regulation: Studies revealed that contact sites are dynamically regulated according to cellular metabolic needs

• Specialized Contact Site Components: Identified that different contact sites have specialized protein compositions for specific functions

Future Research Directions Enabled:

• Investigation of contact site proteomes using PEX28 antibody as an entry point

• Studies of contact site dynamics during cellular stress responses

• Comparative analysis of contact site architecture across species

• Integration of contact site biology with broader cellular physiology